|
Complications of intravenous Streptokinase therapy in acute myocardial infarction patients admitted to the cardiac intensive care unit
|
Sedigheh Fayazi1   , Mohammad-Hashem Abdi2 , Neda Sayadi *3 , Shahnaz Rostami4 |
1- Master of Science in Medical-Surgical Nursing, Faculty of Nursing and Midwifery, Jundishapur University of Medical Sciences, Ahvaz, Iran
2- School of Nursing and Paramedicine, Jahrom University of Medical Sciences, Jahrom, Iran
3- Master of Science in Medical-Surgical Nursing, Faculty of Nursing and Midwifery, Jundishapur University of Medical Sciences, Ahvaz,Iran (*Corresponding Author) , saed_sayadi@yahoo.com
4- Assistant Professor of Nursing, Faculty of Nursing and Midwifery, Jundishapur University of Medical Sciences, Ahvaz, Iran |
|
|
Abstract: (16381 Views) |
Abstract Aim. The aim of this study was to evaluate complications of intravenous Streptokinase therapy in acute myocardial infarction patients admitted to the cardiac intensive care unit. Background. Myocardial infarction is a common disease and the use of thrombolytic agents such as Streptokinase reduces its mortality, but there are some complications associated with streptokinase. Method. In this descriptive stud y 120, patients treated with streptokinase were evaluated in terms of complications of the drug. A checklist of Streptokinase complications was used to collect the data. The findings were presented in the form of descriptive and inferential statistics. Findings. According to the finding s, %33.3 of patients had cardiovascular complications, %23.9 developed allergic symptoms, and %17.5 suffered blood complications. Conclusion. The incidence of cardiac complications was the highest among patients. It is recommended to train nurses to avoid possible complications. |
|
| Keywords: Streptokinase complications, Myocardial infarction, Cardiac intensive care unit |
|
|
Full-Text [PDF 229 kb]
(19681 Downloads)
|
: Research |
Subject:
Cardiovascular
Received: 2013/10/24 | Accepted: 2013/10/26 | Published: 2013/11/02 | ePublished: 2013/11/02
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
